Crossmark

Comparative effectiveness of CDK4/6 inhibitors in metastatic breast cancer: using the target trial emulation framework to investigate overall survival in routine care

Crossref DOI link: https://doi.org/10.1007/s10549-026-07935-3

Published Online: 2026-03-07

Published Print: 2026-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Brufsky, Adam M. https://orcid.org/0000-0001-8080-7960
Finn, Richard S. https://orcid.org/0000-0003-2494-2126
Metzger, Otto https://orcid.org/0000-0003-0792-0320
Goncalves, Rodrigo https://orcid.org/0000-0002-3513-0214
Huang-Bartlett, Cynthia https://orcid.org/0000-0003-2003-2213
Sreenivasan, Sameet https://orcid.org/0000-0001-5785-8815
Nur, Ula https://orcid.org/0000-0001-8203-7226
Davies, Jessica

Grigorenko, Alex https://orcid.org/0009-0000-6723-8695
Long, Gráinne H. https://orcid.org/0009-0001-4074-4536
License Information

Text and Data Mining valid from 2026-03-07

Version of Record valid from 2026-03-07
More Information

Article History

Received: 15 August 2025

Accepted: 20 February 2026

First Online: 7 March 2026